328 related articles for article (PubMed ID: 30393107)
41. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.
Henke A; Zell R; Ehrlich G; Stelzner A
J Virol; 2001 Sep; 75(17):8187-94. PubMed ID: 11483764
[TBL] [Abstract][Full Text] [Related]
42. Sex Hormone Contributes to Sexually Dimorphic Susceptibility in CVB3-Induced Viral Myocarditis via Modulating IFN-γ
Zhou N; Yue Y; Xiong S
Can J Cardiol; 2018 Apr; 34(4):492-501. PubMed ID: 29455951
[TBL] [Abstract][Full Text] [Related]
43. Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis.
Van Linthout S; Savvatis K; Miteva K; Peng J; Ringe J; Warstat K; Schmidt-Lucke C; Sittinger M; Schultheiss HP; Tschöpe C
Eur Heart J; 2011 Sep; 32(17):2168-78. PubMed ID: 21183501
[TBL] [Abstract][Full Text] [Related]
44. The outcome of coxsackievirus B3-(CVB3-) induced myocarditis is influenced by the cellular immune status.
Leipner C; Grün K; Borchers M; Stelzner A
Herz; 2000 May; 25(3):245-8. PubMed ID: 10904846
[TBL] [Abstract][Full Text] [Related]
45. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice.
Huber SA; Feldman AM; Sartini D
Circ Res; 2006 Nov; 99(10):1109-16. PubMed ID: 17038643
[TBL] [Abstract][Full Text] [Related]
46. Selenium deficiency contributes to the chronic myocarditis in coxsackievirus-infected mice.
Jun EJ; Ye JS; Hwang IS; Kim YK; Lee H
Acta Virol; 2011; 55(1):23-9. PubMed ID: 21434702
[TBL] [Abstract][Full Text] [Related]
47. Involvement of Endoplasmic Reticulum Stress-Mediated C/EBP Homologous Protein Activation in Coxsackievirus B3-Induced Acute Viral Myocarditis.
Cai Z; Shen L; Ma H; Yang J; Yang D; Chen H; Wei J; Lu Q; Wang DW; Xiang M; Wang J
Circ Heart Fail; 2015 Jul; 8(4):809-18. PubMed ID: 25985795
[TBL] [Abstract][Full Text] [Related]
48. [Protective effect of hydrogen sulfide on mice with experimental viral myocarditis and its mechanism].
Qian H; Liu L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):708-12. PubMed ID: 25001934
[TBL] [Abstract][Full Text] [Related]
49. Wnt11 gene therapy with adeno-associated virus 9 improves the survival of mice with myocarditis induced by coxsackievirus B3 through the suppression of the inflammatory reaction.
Aoyama Y; Kobayashi K; Morishita Y; Maeda K; Murohara T
J Mol Cell Cardiol; 2015 Jul; 84():45-51. PubMed ID: 25886696
[TBL] [Abstract][Full Text] [Related]
50. Blocking the IL-1β signalling pathway prevents chronic viral myocarditis and cardiac remodeling.
Kraft L; Erdenesukh T; Sauter M; Tschöpe C; Klingel K
Basic Res Cardiol; 2019 Jan; 114(2):11. PubMed ID: 30673858
[TBL] [Abstract][Full Text] [Related]
51. Liver X receptor activation enhances CVB3 viral replication during myocarditis by stimulating lipogenesis.
Papageorgiou AP; Heggermont W; Rienks M; Carai P; Langouche L; Verhesen W; De Boer RA; Heymans S
Cardiovasc Res; 2015 Jul; 107(1):78-88. PubMed ID: 25998987
[TBL] [Abstract][Full Text] [Related]
52. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production.
Liu H; Li M; Song Y; Xu W
Front Immunol; 2018; 9():2479. PubMed ID: 30410495
[TBL] [Abstract][Full Text] [Related]
53. IL-21R expression on CD8+ T cells promotes CD8+ T cell activation in coxsackievirus B3 induced myocarditis.
Liu W; Dienz O; Roberts B; Moussawi M; Rincon M; Huber SA
Exp Mol Pathol; 2012 Jun; 92(3):327-33. PubMed ID: 22465422
[TBL] [Abstract][Full Text] [Related]
54. Effect of prophylactically applied CpG ODN on the development of myocarditis in mice infected with Coxsackievirus B3.
Zhao T; Wu X; Song D; Fang M; Guo S; Zhang P; Wang L; Wang L; Yu Y
Int Immunopharmacol; 2012 Dec; 14(4):665-73. PubMed ID: 23063973
[TBL] [Abstract][Full Text] [Related]
55. IL-33 enhances macrophage M2 polarization and protects mice from CVB3-induced viral myocarditis.
Wang C; Dong C; Xiong S
J Mol Cell Cardiol; 2017 Feb; 103():22-30. PubMed ID: 28041873
[TBL] [Abstract][Full Text] [Related]
56. Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2.
Huber SA; Polgar J; Schultheiss P; Schwimmbeck P
J Virol; 1994 Jan; 68(1):195-206. PubMed ID: 8254729
[TBL] [Abstract][Full Text] [Related]
57.
Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
[TBL] [Abstract][Full Text] [Related]
58. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis.
Zhang L; Parham NJ; Zhang F; Aasa-Chapman M; Gould EA; Zhang H
Vaccine; 2012 Mar; 30(13):2301-8. PubMed ID: 22306858
[TBL] [Abstract][Full Text] [Related]
59. Protein Kinase B2 (PKB2/AKT2) Is Essential for Host Protection in CVB3-Induced Acute Viral Myocarditis.
Kim SH; Shin HH; Kim JH; Park JH; Jeon ES; Lim BK
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163412
[TBL] [Abstract][Full Text] [Related]
60. Manipulating intestinal immunity and microflora: an alternative solution to viral myocarditis?
Qian Q; Xiong S; Xu W
Future Microbiol; 2012 Oct; 7(10):1207-16. PubMed ID: 23030425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
